Genome games: A secret meet and a controversy
By Pete Shanks,
Deccan Chronicle
| 05. 22. 2016
On May 10, about 130 scientists, entrepreneurs and others held an invitation-only event at Harvard. Organisers told invitees not to talk to the press and not to discuss pending publications related to the topic they were there to discuss. Wait, what? Were they afraid of public panic? Was an asteroid on its way to destroy Earth? Was a catastrophic virus on the loose?
No, they were discussing future research, and how to get a lot more money for it. But they knew that if word got out people might be upset. Because they discussed building a completely synthetic version of a human genome. Not actually artificial people, but a huge step forward in synthetic biology. One of those invited, Drew Endy, a Stanford professor who is one of the leaders in the field, not only refused to come but tweeted: “If you need secrecy to discuss your proposed research (synthesizing a human genome) you are doing something wrong.”
Private water-cooler chat is certainly one way that ideas are developed. But over 100 people flown in from around the country —...
Related Articles
By Elizabeth Joh, The New York Times | 06.11.2019
Someone broke into a church in Centerville, Utah, last November and attacked the organist who was practicing there. In March, after a conventional investigation came up empty, a police detective turned to forensic consultants at Parabon NanoLabs. Using the publicly...
By Erin Allday, San Francisco Chronicle | 06.15.2019
A new documentary about stem cell therapy is being questioned by some of those who appear in it — prominent cellular scientists who say they weren’t aware of who was backing the project when they agreed to participate.
The 10-part...
By Lori Andrews, Guest Columnist
| 06.18.2019
Editors note: This article was originally published on ourbodiesourselves.org and is reposted here with generous permission from Our Bodies Our Selves.
Six years ago, on June 13, 2013, the U.S. Supreme Court in AMP v. Myriad took a great step forward for women’s health by unanimously ruling that human genes could not be patented. Now a bipartisan group of Senators and Representatives have released a bill that would allow companies to own our genes once again.
Article 1 of...
Six years ago, the question of who, if anyone, could patent a human gene was (we thought) settled by the Supreme Court in what is known as the Myriad decision. Their answer was, no one: human genes may not be patented because a “naturally occurring DNA segment is a product of nature and not patent eligible.”
Unfortunately, a small but influential coalition in Congress is trying hard to overturn that decision.
A key part of the 2013 Supreme Court ruling was to...
